Neuroendocrine prostate cancer (nepc) Clinical Trials
Conditions / Neuroendocrine prostate cancer (nepc)
Delta Trials indexes 2 clinical trials for Neuroendocrine prostate cancer (nepc) in its publicly accessible dataset. Of these, 1 enrolling participants at this time and 0 trials have reached completion. This research takes place spanning 14 research sites around the world. An additional 1 trial are in preparatory or other active non-recruiting stages. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
2
Total Trials
1
Recruiting
0
Completed
1
Other Active
0
Terminated since 2020
14
Study Locations
Browse by location (14 total)
- Chapel Hill, United States 1 trialAll trials in Chapel Hill, United States
- New York, United States 1 trialAll trials in New York, United States
- Duarte, United States 1 trialAll trials in Duarte, United States
- St. Louis, United States 1 trialAll trials in St. Louis, United States
- St. Louis, United States 1 trialAll trials in St. Louis, United States
- Houston, United States 1 trialAll trials in Houston, United States
- Oklahoma City, United States 1 trialAll trials in Oklahoma City, United States
- Fairfax, United States 1 trialAll trials in Fairfax, United States
- Portland, United States 1 trialAll trials in Portland, United States
- Hackensack, United States 1 trialAll trials in Hackensack, United States
- Denver, United States 1 trialAll trials in Denver, United States
- Baltimore, United States 1 trialAll trials in Baltimore, United States
- Nashville, United States 1 trialAll trials in Nashville, United States
- Boston, United States 1 trialAll trials in Boston, United States
- San Antonio, United States 1 trialAll trials in San Antonio, United States